Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index; 35 of the 59 sources its claims cite were checked for support.

Targeting β1-integrin inhibits vascular leakage in endotoxemia

Open access

Abstract

The study shows that inhibiting endothelial β1-integrin can reduce vascular leakage in murine endotoxemia.

Overview

CoChat Summary

TL;DR

Targeting β1-integrin with inhibitory antibodies or heterozygous endothelial deletion reduces LPS-induced vascular leakage in murine endotoxemia, and β1-integrin promotes endothelial contractility and permeability via ANGPT2-dependent α5β1-integrin/tensin-1 fibrillar adhesions. The findings suggest β1-integrin signaling as a potential vascular-stabilization target in pathological leak.

Key findings

  • In cultured human endothelial cells, β1-integrin inhibition with mAb13 (0.1 μg⋅mL−1) prevented thrombin-induced loss of junctional VE-cadherin and monolayer permeability; thrombin increased traction force threefold, and mAb13 attenuated this increase.
  • In murine LPS-induced endotoxemia, HMβ1 (2.5 mg⋅kg−1 i.p.) reduced leakage of 100-nm fluorospheres and 70-kDa dextran in tracheal and dermal vasculature, improved cardiac output by ejection fraction and fractional shortening, and remained effective when given 2 h after LPS.
  • Endothelial β1-integrin silencing (96% mRNA silencing; ~10% active β1-integrin remained) or heterozygous endothelial deletion protected against inflammation-induced junction destabilization and LPS-induced vascular leakage, whereas β3-integrin silencing did not.
  • Inflammatory agents induced ANGPT2-dependent formation of α5β1-integrin– and tensin-1–positive fibrillar adhesions; tensin-1 silencing prevented IL-1β–induced VE-cadherin loss, and ANGPT2 was required for α5-integrin recycling to adhesions.

Methods

  • In vitro studies used primary human dermal blood microvascular ECs, HUVECs, and human pulmonary microvascular ECs stimulated with thrombin, IL-1β, or LPS; readouts included VE-cadherin/ZO-1 staining, electrical cell impedance, traction force microscopy, shRNA silencing, and immunofluorescence.
  • In vivo studies used 2- to 4-mo-old male C57BL/6 mice with LPS (O55:B5, 11 mg⋅kg−1 i.p. for 16 h) endotoxemia; β1- or α4-integrin antibodies or controls were given at 2.5 mg⋅kg−1 i.p., and vascular leakage was measured with 100-nm fluorospheres or 70-kDa dextran, plus echocardiography and TEM.
  • Conditional heterozygous endothelial β1-integrin deletion was tested in tamoxifen-induced Itgb1WT/fl mice; statistical comparisons used Student’s t tests or Tukey’s multiple comparison tests after ANOVA, with P < 0.05 considered significant.

Limitations

  • The paper states that it does not identify the integrin alpha subunit(s) pairing with β1-integrin to promote vascular leakage in vivo, although α5-integrin was implicated in cultured ECs.
  • The paper states that β1-integrin’s ubiquitous expression and versatile function may make it implausible for preventing long-term vascular leakage, and that whether αvβ5-integrin uses similar mechanisms remains to be investigated.
  • Evident from the text: in vivo efficacy is shown in LPS-induced murine endotoxemia, with human data limited to cultured endothelial cells; no human clinical outcomes are reported.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1073/pnas.1722317115

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1. β1-integrin antibody inhibits thrombin-induced endothelial monolayer destabilization. (A) BECs were treated with a control antibody (Ctrl Ab) or a β1-integrin inhibiting antibody (mAb13) (both 0.1 μg⋅mL−1 for 5 min), stimulated with thrombin (Thr) (0.1 U⋅mL−1 for 30 min), and fixed and stained for VE-cadherin or filamentous actin (F-Actin). (B) Quantification of VE-cadherin staining (150 cells per treatment. Data are the mean ± SD of n = 3 independent experiments). (C) BECs were analyzed for electrical cell impedance (represented as the cell index). Stimulation with Ab and thrombin (1 U⋅mL−1) was initiated once the impedance reached saturating levels (set as time 0). The mean ± SD from a representative experiment is shown (four wells per treatment, P = 0.026). (D) BECs were treated with S-Blebbistatin (20 min) and then with thrombin (0.1 U⋅mL−1, 20 min), and fixed and stained for VE-cadherin and F-actin. (E) Representative traction force maps exerted by HUVECs plated on fibronectin-coated polyacrylamide gels. Images were taken at baseline, at 5 min after the addition of mAb13, and after 10 and 20 min of thrombin stimulation (0.1 U⋅mL−1). (F) Quantification of the mean force (strain energy, pJ). Data are the mean ± SD of n = 3 independent experiments. *P < 0.05, **P < 0.01, and ***P < 0.001 (Tukey’s test). Representative images of maximum intensity projections of confocal z-stacks obtained using a 63× objective are shown. Nuclear DAPI stain. (Scale bars: 20 μm.)
Fig. 1. β1-integrin antibody inhibits thrombin-induced endothelial monolayer destabilization. (A) BECs were treated with a control antibody (Ctrl Ab) or a β1-integrin inhibiting antibody (mAb13) (both 0.1 μg⋅mL−1 for 5 min), stimulated with thrombin (Thr) (0.1 U⋅mL−1 for 30 min), and fixed and stained for VE-cadherin or filamentous actin (F-Actin). (B) Quantification of VE-cadherin staining (150 cells per treatment. Data are the mean ± SD of n = 3 independent experiments). (C) BECs were analyzed for electrical cell impedance (represented as the cell index). Stimulation with Ab and thrombin (1 U⋅mL−1) was initiated once the impedance reached saturating levels (set as time 0). The mean ± SD from a representative experiment is shown (four wells per treatment, P = 0.026). (D) BECs were treated with S-Blebbistatin (20 min) and then with thrombin (0.1 U⋅mL−1, 20 min), and fixed and stained for VE-cadherin and F-actin. (E) Representative traction force maps exerted by HUVECs plated on fibronectin-coated polyacrylamide gels. Images were taken at baseline, at 5 min after the addition of mAb13, and after 10 and 20 min of thrombin stimulation (0.1 U⋅mL−1). (F) Quantification of the mean force (strain energy, pJ). Data are the mean ± SD of n = 3 independent experiments. *P < 0.05, **P < 0.01, and ***P < 0.001 (Tukey’s test). Representative images of maximum intensity projections of confocal z-stacks obtained using a 63× objective are shown. Nuclear DAPI stain. (Scale bars: 20 μm.)CC BY-NC-ND · PubMed Central
Fig. 2. Silencing of ANGPT2, β1-integrin, or α5-integrin, but not β3-integrin, inhibits thrombin, IL-1β, or LPS-induced endothelial monolayer destabilization. BECs transfected with shScr or shβ1 lentiviral vectors (A and B) were stimulated with thrombin (1 U·mL−1 for 30 min) and stained for active β1-integrin (12G10) and F-actin (A). (B) Quantification of 12G10 staining (350 cells per treatment, n = 3 independent experiments). BECs transduced with shScr, shβ1, shβ3, shANGPT2, or shα5, as indicated, were stimulated with thrombin (1 U⋅mL−1 for 30 min) (C–E), IL-1β (10 ng⋅mL−1 for 2 h) (F and G), or LPS (2.5 μg⋅mL−1 for 2 h) (G) and stained for VE-cadherin (C, D, and F) or ZO-1 (G). (C and F) Quantification of VE-cadherin staining (120–300 cells per treatment, n = 3 independent experiments). (E) BECs transduced with shScr or shβ1 were analyzed for electrical cell impedance (represented as the cell index). Cells were stimulated with thrombin (1 U⋅mL−1) once the impedance reached saturating levels (set as time 0). A representative experiment is shown (four wells per treatment, mean ± SD, P = 0.0036). (G) Quantification of ZO-1–positive junction length (130 to 145 cells per treatment n = 3 independent experiments). Data are the mean ± SD of n = 3 independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 (Tukey’s test). Representative images of maximum intensity projections of confocal z-stacks obtained using a 63× objective are shown. Nuclear DAPI stain. (Scale bars: 20 μm.)
Fig. 2. Silencing of ANGPT2, β1-integrin, or α5-integrin, but not β3-integrin, inhibits thrombin, IL-1β, or LPS-induced endothelial monolayer destabilization. BECs transfected with shScr or shβ1 lentiviral vectors (A and B) were stimulated with thrombin (1 U·mL−1 for 30 min) and stained for active β1-integrin (12G10) and F-actin (A). (B) Quantification of 12G10 staining (350 cells per treatment, n = 3 independent experiments). BECs transduced with shScr, shβ1, shβ3, shANGPT2, or shα5, as indicated, were stimulated with thrombin (1 U⋅mL−1 for 30 min) (C–E), IL-1β (10 ng⋅mL−1 for 2 h) (F and G), or LPS (2.5 μg⋅mL−1 for 2 h) (G) and stained for VE-cadherin (C, D, and F) or ZO-1 (G). (C and F) Quantification of VE-cadherin staining (120–300 cells per treatment, n = 3 independent experiments). (E) BECs transduced with shScr or shβ1 were analyzed for electrical cell impedance (represented as the cell index). Cells were stimulated with thrombin (1 U⋅mL−1) once the impedance reached saturating levels (set as time 0). A representative experiment is shown (four wells per treatment, mean ± SD, P = 0.0036). (G) Quantification of ZO-1–positive junction length (130 to 145 cells per treatment n = 3 independent experiments). Data are the mean ± SD of n = 3 independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 (Tukey’s test). Representative images of maximum intensity projections of confocal z-stacks obtained using a 63× objective are shown. Nuclear DAPI stain. (Scale bars: 20 μm.)CC BY-NC-ND · PubMed Central
Fig. 3. β1-integrin antibody reduces vascular leakage and improves cardiac output in LPS-induced murine endotoxemia. (A) Analysis of leakage of 100-nm fluorospheres in mice treated with β1-integrin (HMβ1) or control antibodies (Ctrl Ab) for 24 h, followed by LPS or PBS for 16 h. Shown are representative maximum intensity projections of tile-scanned confocal z-stacks of tracheal whole mounts stained for CD31 (green), obtained using a 10× objective. Quantification of fluorosphere area in the trachea (B) and ear (C, corresponding micrographs in SI Appendix, Fig. S8), n = 7 to 8 mice per group. (D) Vascular leakage in mice treated as in A was measured using Texas red-conjugated 70-kDa Dextran. Shown are representative maximum intensity projections of confocal z-stacks of tracheal whole mounts stained for VE-cadherin (green), obtained using a 10× objective. (E) Quantification of fluorescent dextran area in the trachea, n = 3 to 6 mice per group. (F and G) Echocardiographic analysis of mice treated with HMβ1 or Ctrl Ab for 24 h. Heart function was recorded before and 16 h after administration of LPS or PBS. Ejection fraction (F) and fractional shortening values (G) are presented. n = 8 to 13 mice per group. Data are the mean ± SD. *P < 0.05, **P < 0.01, and ***P < 0.001 (Tukey’s test). (Scale bars: 100 μm.)
Fig. 3. β1-integrin antibody reduces vascular leakage and improves cardiac output in LPS-induced murine endotoxemia. (A) Analysis of leakage of 100-nm fluorospheres in mice treated with β1-integrin (HMβ1) or control antibodies (Ctrl Ab) for 24 h, followed by LPS or PBS for 16 h. Shown are representative maximum intensity projections of tile-scanned confocal z-stacks of tracheal whole mounts stained for CD31 (green), obtained using a 10× objective. Quantification of fluorosphere area in the trachea (B) and ear (C, corresponding micrographs in SI Appendix, Fig. S8), n = 7 to 8 mice per group. (D) Vascular leakage in mice treated as in A was measured using Texas red-conjugated 70-kDa Dextran. Shown are representative maximum intensity projections of confocal z-stacks of tracheal whole mounts stained for VE-cadherin (green), obtained using a 10× objective. (E) Quantification of fluorescent dextran area in the trachea, n = 3 to 6 mice per group. (F and G) Echocardiographic analysis of mice treated with HMβ1 or Ctrl Ab for 24 h. Heart function was recorded before and 16 h after administration of LPS or PBS. Ejection fraction (F) and fractional shortening values (G) are presented. n = 8 to 13 mice per group. Data are the mean ± SD. *P < 0.05, **P < 0.01, and ***P < 0.001 (Tukey’s test). (Scale bars: 100 μm.)CC BY-NC-ND · PubMed Central
Fig. 4. β1-integrin antibody reduces vascular leakage after the onset of systemic inflammation. (A) Quantification of circulating levels of IL-6, IL-1β, TNF-α, and ANGPT2 in the serum and Angpt1 mRNA in the lungs of mice challenged with HMβ1 or control antibodies for 24 h, followed by LPS or PBS for the indicated times (n = 3 mice per group). (B) HMβ1 or control antibodies were administered 2 h after the administration of LPS or PBS. Quantification of 100-nm fluorospheres in the vasculature of the trachea and ear 14 h after antibody treatment (n = 5 to 6 mice per group). (C–J) Mice were challenged with HMβ1 or control antibodies for 24 h, followed by LPS or PBS for 16 h. VCAM-1 (D and E) (n = 6 mice per group) and Ly6G/C (F and G) (n = 3 mice per group) staining and quantification in the lungs. Western blot analysis of VCAM-1 (C) (n = 6 mice per group), TIE1 (H) (n = 3 mice per group), TIE2 (I) (n = 6 mice per group), and phospho-TIE2 (J) (n = 6 mice per group) in mouse lung lysates. Dashed line indicates where lanes were cropped together from a single membrane. Data are the mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 (Tukey’s test). (Scale bars: 100 μm.)
Fig. 4. β1-integrin antibody reduces vascular leakage after the onset of systemic inflammation. (A) Quantification of circulating levels of IL-6, IL-1β, TNF-α, and ANGPT2 in the serum and Angpt1 mRNA in the lungs of mice challenged with HMβ1 or control antibodies for 24 h, followed by LPS or PBS for the indicated times (n = 3 mice per group). (B) HMβ1 or control antibodies were administered 2 h after the administration of LPS or PBS. Quantification of 100-nm fluorospheres in the vasculature of the trachea and ear 14 h after antibody treatment (n = 5 to 6 mice per group). (C–J) Mice were challenged with HMβ1 or control antibodies for 24 h, followed by LPS or PBS for 16 h. VCAM-1 (D and E) (n = 6 mice per group) and Ly6G/C (F and G) (n = 3 mice per group) staining and quantification in the lungs. Western blot analysis of VCAM-1 (C) (n = 6 mice per group), TIE1 (H) (n = 3 mice per group), TIE2 (I) (n = 6 mice per group), and phospho-TIE2 (J) (n = 6 mice per group) in mouse lung lysates. Dashed line indicates where lanes were cropped together from a single membrane. Data are the mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 (Tukey’s test). (Scale bars: 100 μm.)CC BY-NC-ND · PubMed Central
Fig. 5. β1-integrin antibody improves endothelial cell junction integrity in endotoxemia. LPS or PBS was administered to mice 24 h after the administration of HMβ1 or control antibody. (A) Representative transmission electron microscopic images of lungs 16 h after LPS or PBS administration. (B) Magnification of the area indicated in A. (C and D) Quantification of the electron-dense areas of endothelial cell–cell junctions relative to total endothelial cell–cell contact in the lungs (C) and (D) trachea, as described in more detail in SI Appendix, SI Materials and Methods and Fig. S14. Data are the mean ± SD of n = 3 mice per group. *P < 0.05, **P < 0.01, and ***P < 0.001 (Tukey’s test). (Scale bars: 1 μm.)
Fig. 5. β1-integrin antibody improves endothelial cell junction integrity in endotoxemia. LPS or PBS was administered to mice 24 h after the administration of HMβ1 or control antibody. (A) Representative transmission electron microscopic images of lungs 16 h after LPS or PBS administration. (B) Magnification of the area indicated in A. (C and D) Quantification of the electron-dense areas of endothelial cell–cell junctions relative to total endothelial cell–cell contact in the lungs (C) and (D) trachea, as described in more detail in SI Appendix, SI Materials and Methods and Fig. S14. Data are the mean ± SD of n = 3 mice per group. *P < 0.05, **P < 0.01, and ***P < 0.001 (Tukey’s test). (Scale bars: 1 μm.)CC BY-NC-ND · PubMed Central
Fig. 6. Heterozygous deletion of endothelial β1-integrin protects from vascular leakage. Vascular leakage of 100-nm fluorospheres was measured in LPS- or PBS-treated Cre-positive tamoxifen-induced Itgb1WT/fl(Itgb1WT/iΔEC) mice or littermate controls (Ctrl) after 16 h. (A) Representative maximum intensity projections of tile-scanned confocal z-stacks of tracheal whole mounts stained for CD31 (green) obtained using a 10× objective. Quantification of fluorosphere area in the trachea (B) and ear skin (C). Ctrl + PBS group: n = 15 (6 WT, 5 Itgb1WT/fl, 4 Pdgfb-iCreERT2 mice). Ctrl + LPS group: n = 10 (4 WT, 5 Itgb1WT/fl, 1 Pdgfb-iCreERT2 mouse). Itgb1WT/iΔEC + PBS group: n = 7. Itgb1WT/iΔEC + LPS group: n = 9. Data are the mean ± SD. *P < 0.05, **P < 0.01, and ***P < 0.001 (Tukey’s test). (Scale bar: 100 μm.)
Fig. 6. Heterozygous deletion of endothelial β1-integrin protects from vascular leakage. Vascular leakage of 100-nm fluorospheres was measured in LPS- or PBS-treated Cre-positive tamoxifen-induced Itgb1WT/fl(Itgb1WT/iΔEC) mice or littermate controls (Ctrl) after 16 h. (A) Representative maximum intensity projections of tile-scanned confocal z-stacks of tracheal whole mounts stained for CD31 (green) obtained using a 10× objective. Quantification of fluorosphere area in the trachea (B) and ear skin (C). Ctrl + PBS group: n = 15 (6 WT, 5 Itgb1WT/fl, 4 Pdgfb-iCreERT2 mice). Ctrl + LPS group: n = 10 (4 WT, 5 Itgb1WT/fl, 1 Pdgfb-iCreERT2 mouse). Itgb1WT/iΔEC + PBS group: n = 7. Itgb1WT/iΔEC + LPS group: n = 9. Data are the mean ± SD. *P < 0.05, **P < 0.01, and ***P < 0.001 (Tukey’s test). (Scale bar: 100 μm.)CC BY-NC-ND · PubMed Central
Fig. 7. Inflammatory agents stimulate the formation of α5β1-integrin– and tensin-1–positive fibrillar adhesions in an ANGPT2-dependent manner. (A and B) BECs expressing paxillin-TagGFP2 were imaged live, every 2 min for 1 h, in the presence or absence of thrombin (1 U⋅mL−1). Representative temporal code images at times 0 to 60 min. (B) Merged images of time 0 (green) and 60 min (magenta). BECs were stimulated with IL-1β (2 h) (C–E) or thrombin (0.1 U⋅mL−1, 30 min) (F) and stained for active β1-integrin (12G10) (C) or α5-integrin (SNAKA51) (D and F), or stimulated with LPS (2.5 μg⋅mL−1, 2 h) and stained for tensin-1 (TNS1) (G). (E) Quantification of the SNAKA51-positive area (160 cells per treatment, n = 3 independent experiments). (H) Quantification of the TNS1-positive area (n = 3 independent experiments). (I) VE-cadherin staining of BECs transduced with shScr or shTNS1 and stimulated with IL-1β (2 h). (J) Quantification of VE-cadherin staining in I (220 to 250 cells per treatment, n = 3 independent experiments). (K) Quantification of the TNS1-positive area in LPS-stimulated BECs transduced with shScr or shANGPT2 (micrographs in SI Appendix, Fig. S19) (n = 3 independent experiments). (L) BECs transfected with shScr or shβ1 were stimulated with recombinant human (rh)ANGPT2 for 2 h and fixed and stained for VE-cadherin (n = 3 independent experiments). (M) BECs transfected with shScr or shANGPT2 were analyzed for α5-integrin recycling, as described in SI Appendix, SI Materials and Methods. Internalized α5-integrin was quantified in cells stimulated with LPS, IL-1β, or thrombin relative to unstimulated, shScr cells after recycling. LPS, IL-1β, and thrombin induced the recycling of internalized α5-integrin from vesicles to cell adhesions in shScr-transduced but not shANGPT2-transduced cells. n = 3 independent experiments. Data are the mean ± SD. *P < 0.05, **P < 0.01, and ***P < 0.001 (Tukey’s test). Nuclear DAPI stain. (Scale bars: 20 μm.) (N) Schematic model of ANGPT2- and α5β1-integrin–mediated endothelial destabilization in response to inflammatory stimuli. In quiescent endothelial monolayers, the cortical actin rim and VE-cadherin–positive cell junctions maintain monolayer integrity. Inflammatory agents induce the formation of α5β1-integrin– and tensin-1–positive fibrillar adhesions, in an ANGPT2-dependent manner. This stabilizes actin stress fibers, increases tension, and destabilizes endothelial cell–cell junctions via loss of junctional VE-cadherin, leading to increased permeability.
Fig. 7. Inflammatory agents stimulate the formation of α5β1-integrin– and tensin-1–positive fibrillar adhesions in an ANGPT2-dependent manner. (A and B) BECs expressing paxillin-TagGFP2 were imaged live, every 2 min for 1 h, in the presence or absence of thrombin (1 U⋅mL−1). Representative temporal code images at times 0 to 60 min. (B) Merged images of time 0 (green) and 60 min (magenta). BECs were stimulated with IL-1β (2 h) (C–E) or thrombin (0.1 U⋅mL−1, 30 min) (F) and stained for active β1-integrin (12G10) (C) or α5-integrin (SNAKA51) (D and F), or stimulated with LPS (2.5 μg⋅mL−1, 2 h) and stained for tensin-1 (TNS1) (G). (E) Quantification of the SNAKA51-positive area (160 cells per treatment, n = 3 independent experiments). (H) Quantification of the TNS1-positive area (n = 3 independent experiments). (I) VE-cadherin staining of BECs transduced with shScr or shTNS1 and stimulated with IL-1β (2 h). (J) Quantification of VE-cadherin staining in I (220 to 250 cells per treatment, n = 3 independent experiments). (K) Quantification of the TNS1-positive area in LPS-stimulated BECs transduced with shScr or shANGPT2 (micrographs in SI Appendix, Fig. S19) (n = 3 independent experiments). (L) BECs transfected with shScr or shβ1 were stimulated with recombinant human (rh)ANGPT2 for 2 h and fixed and stained for VE-cadherin (n = 3 independent experiments). (M) BECs transfected with shScr or shANGPT2 were analyzed for α5-integrin recycling, as described in SI Appendix, SI Materials and Methods. Internalized α5-integrin was quantified in cells stimulated with LPS, IL-1β, or thrombin relative to unstimulated, shScr cells after recycling. LPS, IL-1β, and thrombin induced the recycling of internalized α5-integrin from vesicles to cell adhesions in shScr-transduced but not shANGPT2-transduced cells. n = 3 independent experiments. Data are the mean ± SD. *P < 0.05, **P < 0.01, and ***P < 0.001 (Tukey’s test). Nuclear DAPI stain. (Scale bars: 20 μm.) (N) Schematic model of ANGPT2- and α5β1-integrin–mediated endothelial destabilization in response to inflammatory stimuli. In quiescent endothelial monolayers, the cortical actin rim and VE-cadherin–positive cell junctions maintain monolayer integrity. Inflammatory agents induce the formation of α5β1-integrin– and tensin-1–positive fibrillar adhesions, in an ANGPT2-dependent manner. This stabilizes actin stress fibers, increases tension, and destabilizes endothelial cell–cell junctions via loss of junctional VE-cadherin, leading to increased permeability.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

24 Valid · 1 Not valid · 12 Not checked · 108 Own results and interpretations

89 more claims · 1 with their cited sources checked

Create a free account to see all 145 claims and to verify the 1 reference still open.

See all claims — free account
  • Probably not a substantial claim. 20
  • It may state two separate claims as one. 35
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Citations

Cites

Show all 35 references

Cited by

See all 96

Metadata

Authors
Hakanpaa, L., Kiss, E. A., Jacquemet, G., Miinalainen, I., Lerche, M., Guzmán, C., Mervaala, E., Eklund, L., Ivaska, J., & Saharinen, P.
Affiliations
  • Translational Cancer Biology Program, Research Programs Unit, Biomedicum Helsinki, University of Helsinki, FI-00014 Helsinki, Finland;
  • University of Helsinki (FI)
  • Åbo Akademi University (FI)
  • University of Oulu (FI)
Corresponding author
Saharinen, Pipsa
Venue
Proceedings of the National Academy of Sciences
Published
2018-06-25
Volume
115
Issue
28
Pages
E6467-E6476
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2810667939
Cited by
95
References
35
Citations by year
2026: 7 · 2025: 7 · 2024: 14 · 2023: 7 · 2022: 12 · 2021: 18 · 2020: 19 · 2019: 9 · 2018: 2
FWCI
10.69
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • UTUPub (University of Turku) (submittedVersion)
  • Työväentutkimus Vuosikirja (submittedVersion)
  • Åbo Akademi University Research Portal (submittedVersion)
Funders
  • Helsingin Yliopisto
  • Turun Yliopisto
  • Syöpäjärjestöt
  • Helsinki Institute of Life Science, Helsingin Yliopisto
  • Biocenter, University of Oulu (251314)
Topics
  • Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
beta1 integrin, angiopoietin-2, vascular leakage, endotoxemia, endothelial barrier function, lipopolysaccharide, VE-cadherin, endothelial junctions, alpha5beta1 integrin, integrin signaling, sepsis, heart failure, stress fibers
MeSH terms
Cadherin 5, Animals, Disease Models, Animal, Intercellular Junctions, Lipopolysaccharides, Mice, Transgenic, Antigens, CD, Cadherins, Integrin beta1, Endotoxemia, Protein Transport, Integrin alpha5beta1, Endothelial Cells, Receptor, TIE-2, Mice, Interleukin-1beta

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting β1-integrin inhibits vascular leakage in endotoxemia. https://app.cochat.ai/papers/10.1073/pnas.1722317115
The paper
Hakanpaa, L., Kiss, E. A., Jacquemet, G., Miinalainen, I., Lerche, M., Guzmán, C., Mervaala, E., Eklund, L., Ivaska, J., & Saharinen, P. (2018). Targeting β1-integrin inhibits vascular leakage in endotoxemia. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1722317115

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.